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Introduction 
Adenosine (ADO) is an abundant endogenous neuromodulator, with a generally 
suppressive effect on excitatory synaptic transmission. It is a metabolite of adenosine 
triphosphate (ATP), hence its ubiquitous presence in the central nervous system. Due in 
part to its role as a cellular energy molecule, adenosine finds its way into regulating key 
functions in the brain during both non-pathological and pathological states. In particular, 
the A1 adenosine receptor subtype has the unique role of inhibiting synaptic 
transmission both pre and postsynaptically. Much attention has been focused on the 
role of adenosine in modulating specific excitatory glutamatergic channels, alpha-
amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate 
(NMDA). The heterogeneity of adenosine receptors and their sometimes opposing 
affects on excitatory transmission has made the exact role of adenosine complex. Part 
of the excitement around adenosine is created by a desire to understand how NMDA 
receptors are modulated by it. Previous research has shown that in different brain 
structures adenosine may have heterogeneous effects on the balance of NMDA 
receptor and non-NMDA receptor-mediated currents. In pyramidal neurons of the 
hippocampus, adenosine proportionally reduced the NMDA and non-NMDA mediated 
excitatory currents (Garaschuk, Kovalchuk, & Krishtal, 1992), whereas in dopaminergic 
neurons of rat midbrain, adenosine preferentially reduced NMDA currents (Y.-N. Wu, 
Shen, & Johnson, 1999), thus leading to a decreased ratio of NMDA/non-NMDA 
currents. It is known that in layer 2/3 pyramidal neurons of rat visual cortex, adenosine 
suppresses excitatory synaptic transmission (N. Bannon, Zhang, Ilin, Chistiakova, & 
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Volgushev, 2014). However, it remains unknown whether adenosine has the same 
effect on NMDA and AMPA-mediated currents.  Here we asked whether NMDA-
mediated currents are suppressed by adenosine differentially from AMPA-mediated 
currents, or whether the NMDA/AMPA balance is maintained in synaptic responses of 
layer 2/3 pyramidal neurons during application of adenosine.  
To test this, we conducted in vitro whole-cell recordings from layer 2/3 pyramidal 
neurons in slices from rat visual cortex and, studied synaptic currents evoked with 
stimulating electrodes located in layer 4. Mixed excitatory postsynaptic currents 
composed of AMPA and NMDA-mediated components were recorded on the 
background of blockade of inhibition by 2-100µM picrotoxin (PTX). The identity of AMPA 
and NMDA currents was confirmed pharmacologically using selective antagonists 
DNQX and APV.  Application of adenosine (20µM) led to a proportional decrease of 
NMDA and AMPA mediated currents, so that their balance in compound responses was 
maintained.  These results were confirmed with recording of isolated NMDA currents 
and isolated AMPA currents, which showed a similar reduction in amplitude. Thus, in 
synaptic inputs to layer 2/3 pyramidal neurons of rat visual cortex, adenosine reduces 
the amplitude of NMDA and AMPA-mediated currents proportionally.  
Adenosine at the synapse 
In order to appreciate the larger consequences of adenosine modulation it is 
important to consider how adenosine is introduced to the synapse. Vesicular release of 
neurotransmitters such as acetylcholine, norepinephrine, and 5-HT is often 
accompanied by adenine nucleotides (Dunwiddie, Diao, & Proctor, 1997; Silinsky, 
1975), and activation of adenylyl cyclase leads to diffusion of cAMP into the 
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extracellular space (Rosenberg & Li, 1995). Both sources of adenine nucleotides are 
metabolized from their precursors to adenosine monophosphate (AMP) and 
subsequently to the purine adenosine by 5’-nucleotidase in a rate-limiting step 
(Dunwiddie et al., 1997). An additional source of adenosine at the synapse may also be 
generated during times of high energy demand when the cell metabolizes ATP. Since 
the intracellular concentrations of ATP are in the millimolar range (approx. 3 mM) and 
AMP in the nanomolar, a relatively small amount of ATP must be metabolized to create 
a significant increase in AMP concentration (R.A. Cunha, 2001; Rodrigo A. Cunha, 
2008; Dunwiddie & Masino, 2001). Intracellular AMP is then converted into adenosine 
via 5’-nucleotidase—an opposing reaction with adenosine kinase (Decking, Schlieper, 
Kroll, & Schrader, 1997; Kroll, Decking, Dreikorn, & Schrader, 1993). In an alternative 
pathway adenosine is generated by a transmethylation reaction where S-
adenosylhomocysteine hydrolase converts S-adenosylhomocysteine into adenosine 
and homocysteine.  Once sufficient concentrations of adenosine accumulate within the 
cell it may flow via facilitated diffusion to the extracellular space through nucleoside 
transporters (Dunwiddie & Masino, 2001). 
In the hippocampus, it has been reported that astrocytes may also contribute to 
an increase in extracellular adenosine (Pascual et al., 2005). Gliotransmission begins 
with activation of astrocytic receptors by neurotransmitters, which cause an increase of 
intracellular Ca2+ leading to release of ATP into the extracellular space (Halassa, Fellin, 
& Haydon, 2007). Once in the extracellular space, ATP is quickly metabolized to 
adenosine by ecto-nucleotidases. 
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Despite the variety of ways adenosine is introduced to the synapse there exists a 
common theme, that is—adenosine release is activity-dependent. In a study conducted 
by Pajski and Venton (2013), they demonstrated an activity-dependent release of 
adenosine following extracellular stimulation in caudate-putamen, nucleus accumbens, 
hippocampus, and cortex. This was corroborated by introduction of a Ca2+chelator or 
tetrodotoxin that nearly abolished adenosine release (Pajski & Venton, 2013). The local 
concentrations of adenosine also varied depending on brain region with the caudate-
putamen having the highest concentrations (0.34 M) and the secondary motor cortex 
the lowest (0.06M). The extracellular breakdown of ATP following vesicular release 
was the primary mechanism of adenosine formation in nucleus accumbens, 
hippocampus, and prefrontal cortex whereas adenosine in the caudate-putamen was 
glutamate-receptor dependent. The differing sources and concentrations of adenosine 
by brain regions highlights that adenosine may have differential effects on synaptic 
transmission in differing brain regions. 
 The clearance of adenosine from the extraceullar space can be accomplished by 
two prevailing mechanisms. Adenosine can be degraded at the synapse into its inert 
form inosine by adenosine deaminase. However, under non-energetically demanding 
circumstances intracellular concentrations of adenosine favor diffusion into the cell 
where adenosine kinase captures it by phosphorylation. The latter mechanism is 
thought to play a larger role in clearing adenosine from the synapse as adenosine 
deaminase antagonism has little effect on extracellular adenosine concentration 
(Dunwiddie & Masino, 2001; Lloyd & Fredholm, 1995; Pak, Haas, Decking, & Schrader, 
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1994). This result makes intuitive sense due to the concentration gradient favoring 
adenosine flowing into the cell from the extracellular space. 
  
Adenosine Receptors (A1, A2A, A2B, A3) 
 Currently, there are four adenosine receptors (A1R, A2AR, A2BR, A3R) that have 
been isolated and cloned in variety of species including human (Olah & Stiles, 1995). 
Each adenosine receptor is part of the G-protein coupled receptor family (Dunwiddie & 
Masino, 2001; Olah & Stiles, 1995). The functions of each receptor depend on both their 
location at the synapse (pre- or postsynaptic) and their effects on intracellular targets. 
 The A1R is the most widely expressed adenosine receptor in all regions of the 
brain (Dixon, Gubitz, Sirinathsinghji, Richardson, & Freeman, 1996). The most common 
function of the A1 receptor is the reduction in vesicular release probability by reducing 
calcium influx into the presynaptic terminal through N-type Ca2+ channels (Gomes, 
Kaster, Tomé, Agostinho, & Cunha, 2011; Gundlfinger et al., 2007; L.-G. Wu & Saggau, 
1994, 1997). There may also be an effect of presynaptic A1R agonism downstream of 
Ca2+ influx that reduce release probability but the mechanisms are unclear (Yawo & 
Chuhma, 1993). However, the net effect of presynaptic A1R activation appears to be the 
reduction in release of glutamate, aspartate, acetylcholine, and serotonin (Corradetti, Lo 
Conte, Moroni, Beatrice Passani, & Pepeu, 1984; Fontanez & Porter, 2006; Lupica, 
Proctor, & Dunwiddie, 1992; Silinsky, 1984). It has also been demonstrated that A1R 
activation can reduce GABAergic inhibitory transmission in the neocortex (Kirmse, 
Dvorzhak, Grantyn, & Kirischuk, 2008; Zhang, Bannon, Ilin, Volgushev, & Chistiakova, 
2015). Postsynaptic A1 receptors affect synaptic transmission in both cortical and 
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subcortical brain regions (Kim & Johnston, 2015; Takigawa & Alzheimer, 1999; L. O. 
Trussell & Jackson, 1985). Post-synaptic A1 receptors act on G-protein coupled inwardly 
rectifying potassium channels (GIRKs) causing a hyperpolarization of the membrane—
making the neuron less excitable (Thompson, Haas, & Gähwiler, 1992; L. Trussell & 
Jackson, 1987; L. O. Trussell & Jackson, 1985). Thus, the main action of the A1R is to 
suppress excitatory synaptic transmission regardless of its location pre- or postsynaptic. 
 The A2A receptor opposes the suppressive effects of the A1 receptor which may 
allow for a dynamic tuning of synapses. However, compared to the A1 receptor the A2A 
receptor is not widely distributed but is found in high concentrations in the basal ganglia 
and low concentrations in other brain areas like cortex (Rodrigo A. Cunha, 2005). In 
addition, the A2A receptors in the basal ganglia are largely postsynaptic where they may 
depolarize neurons (Rodrigo A. Cunha, 2005). In the hippocampus, postsynaptic A2A 
receptors activated by the selective agonist CGS 21680 slowly depolarized the 
membrane and increased the amplitude of evoked excitatory post synaptic potentials 
(H. Li & Henry, 1998).  However, presynaptic A2A receptors facilitate the release of 
neurotransmitters such as glutamate, GABA, glycine, acetylcholine, noradrenaline, and 
serotonin (Rodrigo A. Cunha, 2005). The co-localization of A1 and A2A receptors in the 
hippocampus and striatum suggests there may be a tuning of glutamatergic synapses 
between the inhibitory A1Rs and facilitating A2ARs (Rodrigo A. Cunha, 2005; Rebola, 
Rodrigues, et al., 2005). This effect may be achieved by presynaptic A1R-A2AR 
heteromers where A2A agonism can decrease the affinity of the A1R for adenosine 
(Luísa V. Lopes, Cunha, & Ribeiro, 1999; L.V. Lopes, Cunha, Kull, Fredholm, & Ribeiro, 
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2002). This effect on excitatory synaptic transmission highlights the potential for a 
dynamic relationship between the A1 and A2A receptors pre and postsynaptically. 
 The A2B receptor has been found in all tissues of the central nervous system by 
in situ hybridization (Dixon et al., 1996; Feoktistov & Biaggioni, 1997). However, the 
function of the A2B receptor is unclear, it has been characterized as a low affinity 
receptor (Feoktistov & Biaggioni, 1997) which makes studying the physiological 
implications of A2BR agonism difficult. Similar to the A2A receptor, A2BR activation 
converge on stimulation of adenyl cyclase but only A2B agonism leads to the activation 
of phospholipase C. The consequence of this difference is still under debate but A2B 
receptors are thought to function similar to A2A in that they facilitate excitatory synaptic 
transmission by an increase of presynaptic Ca2+ influx at terminals (Feoktistov & 
Biaggioni, 1997). In all likelihood, the A2B receptor is not a key player under normal 
physiological conditions but rather when adenosine tone increases dramatically during 
pathological states such as ischemia or trauma. 
 The A3 receptor has been identified in many brain tissues of the central nervous 
system but had lower concentrations in the cortex as compared to subcortical structures 
(striatum, nucleus accumbens, olfactory bulb, hippocampus, cerebellum, hypothalamus, 
and thalamus; Dixon et al., 1996). Similar to the A2BR, the A3 receptor is a low affinity 
adenosine receptor (Luísa V. Lopes et al., 2003). The A3 receptor is the most poorly 
understood adenosine receptor and likely only serves a function during 
pathophysiological states (Gessi et al., 2008). Most of the effects of adenosine as a 
neuromodulator can be attributed to the actions of the A1R in most brain areas and A2AR 
in the basal ganaglia.  
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Adenosine in normal physiology 
While adenosine may act first at the molecular and synaptic level it is important 
to consider the broader implications adenosine has on normal physiological 
phenomena. Adenosine has long been studied in the context of arousal or neuronal 
excitability, the sleep/wake cycle, and its role in neuroprotection. In addition, it should be 
mentioned that while adenosine is ubiquitous in the central nervous system it modulates 
the activity of brain regions differently due to both their intrinsic differences in structure 
and adenosine receptor distributions. In the section that follows the heterogeneity of 
adenosine’s actions in specific brain regions will be highlighted.  
Sleep 
 Perhaps the most familiar way to modulate the normal role of adenosine is 
through caffeine, a mild stimulant frequently consumed to promote arousal and 
wakefulness. When consumed, caffeine acts as a non-selective adenosine antagonist 
which likely has an affect on A1 and A2A receptors leading to an increase in neuron 
excitation (Bjorness & Greene, 2009; Ferre et al., 2008). As one may expect, the 
opposing affect of adenosine agonists is to promote sleep behavior (Bjorness & Greene, 
2009). Thus, it makes intuitive sense that adenosine levels rise during the day to 
promote sleep behavior and decrease during sleep. However, this simplified model of 
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sleep falls short of its true complexity due to the functional differences between brain 
areas. 
 In the mesopontine tegmentum, adenosine inhibits neurons in the cholinergic 
arousal system by reducing evoked EPSCs and GABAergic IPSCs. This reduction in 
glutamatergic, cholinergic, and GABAergic synaptic transmission promotes sleep 
behavior and influences thalamocortical neural activity characteristic of slow wave sleep 
(Bjorness & Greene, 2009; Rainnie, Grunze, McCarley, & Greene, 1994). The A1 
receptor is thought to mediate slow wave activation via the interaction between the brain 
stem and thalamocortical neurons. Under an increased adenosine tone, thalamic and 
cortical neurons have increased GIRK channel conductance and relatively less activity 
due to A1R presynaptic inhibition (Bjorness & Greene, 2009). The end result of this 
modulation is a switch from a tonic firing to burst firing pattern of thalamocortical 
neurons; this firing pattern corresponds to delta waves seen on an EEG (Bjorness & 
Greene, 2009; Halassa, 2011).  
 Another key player in sleep behavior is the basal forebrain. Much like the 
mesopontine tegmentum, the basal forebrain contains cholinergic neurons responsible 
for arousal which are more active during waking states or REM sleep. Adenosine 
agonists perfused to the basal forebrain promote sleep behavior whereas antagonists 
achieved the opposite effect (Bjorness & Greene, 2009; Strecker et al., 2000). In 
addition, experiments involving sleep deprivation show increased adenosine tone in 
cortex as well as basal forebrain. However, after prolonged deprivation adenosine tone 
is only stable or increasing in basal forebrain (Bjorness & Greene, 2009). The 
implications of this finding suggest that rising adenosine levels during waking periods 
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reduce the activity of cholinergic and non-cholinergic neurons in the basal forebrain 
which results in sleep behavior. 
 The preoptic/anterior hypothalamus (POAH) and ventrolateral preoptic area 
(VLPO) have ‘sleep active’ neurons that preferentially fire during SWS. Interestingly, 
these neurons are indirectly activated by adenosine via the presynaptic reduction of 
GABAA release from inhibitory neurons onto the ‘sleep active’ neurons. Again, the net 
effect of this disinhibition of GABAergic transmission is a transition from wake behavior 
to SWS (Strecker et al., 2000). 
 Generally, adenosine’s role in the sleep/wake cycle is to reduce synaptic activity 
through the activation of A1 receptors. However, this activation has different 
consequences in different brain regions. Thalamocortical neurons experience a shift 
between tonic and burst firing due to increased GIRK conductance and a reduction in 
presynaptic release probability. Whereas hypothalamic ‘sleep active’ neurons are 
disinhibited by presynaptic A1R activation. Also, the cholinergic and non-cholinergic 
neurons responsible for arousal in mesopontine tegmentum and basal forebrain are 
inhibited by rising adenosine tone. The ability of adenosine to modulate these vastly 
different networks in such a concerted manner truly highlights its potential to influence 
other phenomena in the central nervous system. 
Neuroprotection 
 The function of adenosine as an endogenous neuroprotector stems from its role 
in reducing excitatory synaptic transmission. As was stated before, during times of high 
energetic demand a neuron will expend large amounts of ATP which lead to an increase 
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of adenosine tone. This mechanism seems to be important in mitigating the damage 
caused during epileptic seizures (During & Spencer, 1992) and other excitotoxic events. 
Evidence of increased adenosine concentrations following ischemic or hypoxic events 
have also been reported in both in vitro and in vivo studies. The following section will 
highlight the function of adenosine as an endogenous neuroprotector during times when 
a neural network may be stressed. 
 When considering the neuroprotecive role of adenosine, the A1 receptor 
becomes the center of focus due to its role in dampening excitatory glutamatergic 
transmission. Selective A1R agonists have been shown to reduce neuronal death in 
experimentally induced hypoxia, ischemia, and epilepsy (Rodrigo A. Cunha, 2005; de 
Mendonça, Sebastião, & Ribeiro, 2000). Conversely, selective A1R antagonists 
exacerbate the damage caused by these pathologies. The exact mechanisms have yet 
to be determined but likely reduce NMDA receptor activation by inhibiting glutamate 
release at the synapse. However, adenosine receptors located in tissue outside the 
CNS such as heart make clinical application of adenosine agonists dangerous; A1R 
activation in heart causes bradycardia (Dunwiddie & Masino, 2001). 
 Although considerably less abundant than the A1R in healthy tissue, the A2A 
receptor may provide a clinical target for treatments. The logic behind this argument 
rests in a long-term downregulation of A1Rs and upregulation of A2ARs in tissue that is 
chronically challenged with noxious stimuli such as epileptic seizures or ischemia 
(Rodrigo A. Cunha, 2005; Rebola et al., 2003). The consequence of this ‘flipped’ 
adenosine receptor density is a shift from a tonic inhibitory effect of adenosine on 
excitatory transmission to a facilitating. Interestingly, this phenomena was observed in 
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the cerebral cortex where A2ARs are typically less concentrated (Rebola, Porciúncula, et 
al., 2005). Multiple experiments have confirmed that A2A antagonists provide robust 
neuroprotection when neurons are challenged with noxious stimuli (Rodrigo A. Cunha, 
2005).  
 Astrocytes have become increasingly important in understanding the role of 
adenosine during epileptic seizures. Evidence that astrocytes contribute to endogenous 
adenosine tone comes from experiments with dominant negative mutation of soluble N-
ethylmaleimde-sensitive factor mice (dsSNARE-mice). In these mutants, astrocytes are 
unable to release ATP normally because they lack the docking proteins required for 
release; this caused a loss in tonic adenosine suppression (Pascual et al., 2005). Under 
normal ATP release from astrocytes, ATP is rapidly metabolized to adenosine via 
several ectonucleotidases. As was discussed above, the extracellular adenosine is 
taken up by astrocytes and captured by adenosine kinase (ADK) thus changes in ADK 
will dramatically effect adenosine tone (Boison, 2012). In the hippocampus, an in vitro 
experiment demonstrated pharmacological blockade of ADK caused an increase in 
synaptic adenosine which decreased glutamatergic excitatory synaptic transmission in 
an A1R dependent fashion (Boison, 2012; Etherington et al., 2009). Seizure activity 
induced by high frequency stimulation was significantly reduced under ADK inhibition. 
However, the blockade of ADK did not effect activity-dependent release of adenosine 
therefore the increase in adenosine is likely attributable ADK housed in astrocytes 
(Boison, 2012; Etherington et al., 2009). Further evidence suggesting astrocytes role in 
epilepsy comes from an in vivo study that induced mesial temporal lobe epilepsy 
(MTLE) seizures by causing astrogliosis (an increase in astrocytes secondary to neuron 
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death) and overexpression of ADK in CA3 region of the hippocampus and amygdala 
(Boison, 2012). 
 Adenosine clearly has a role as a natural break on seizure activity. When the 
neurons fire during a seizure there is an activity-dependent release of adenosine which 
acts on A1Rs to reduce further excitation. In addition, astrocytes may release ATP to 
increase local adenosine concentrations. However, it should be mentioned that much of 
the research in epilepsy has been conducted in vitro and in subcortical structures; more 
research is needed in order to elucidate adenosine’s role in seizures in the neocortex. 
NMDA and AMPA Receptors 
 Excitatory synaptic transmission is mediated by four types of ionotropic 
glutamate receptors, delta-, kainate, alpha-amino-3-hydroxyl-5-methyl-4-
isoxazolepropionic acid (AMPA), and N-methyl-D-aspartate (NMDA) receptors. The 
latter two receptors, AMPA and NMDA, have been researched extensively for their roles 
in synaptic transmission. The following section discusses the structure and function of 
AMPA and NMDA receptors with an emphasis on the NMDA receptor due to its key role 
as a detector of pre/post-synaptic activity and synaptic plasticity. 
 In general, ionotropic glutamate receptors are integral membrane proteins 
composed of four subunits that form a channel in the membrane that allows the 
passage of cations. The AMPA receptor is composed of four subunits (GluA1-GluA4) 
which can form both homo- or heteromers. The NMDA receptor is composed of 
combinations of homomers (two GluN1 with two GluN2 subunits or two GluN1 with one 
GluN1 and GluN3). In addition to binding glutamate, NMDA receptors must bind glycine 
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to open; the GluN1/GluN3 subunits bind glycine and GluN2 glutamate (Traynelis et al., 
2010). Functionally, the binding of glutamate is the true determinant of NMDAR 
activation as tonic levels of glycine nearly saturate the co-activation site (Vyklicky et al., 
2014). Another functional caveat of the NMDAR is the variety of GluN2 subunits 
(GluN2A, GluN2B, GluN2C, GluN2D) which have been the focus of recent research but 
will not be mentioned further. 
 The selective ion permeability of AMPA and NMDA receptors is determined by a 
three alpha helical transmembrane domain which creates a pore in the membrane. The 
key difference between AMPA and NMDA receptors in this region is the residues in a 
critical region of the pore known as the QRN site. In AMPA receptors, the QRN site has 
a glutamine or arginine residue whereas the NMDAR has an asparagine residue 
(Traynelis et al., 2010). One consequence of these residues is that AMPA and NMDA 
receptors selectively pass cations such as Na+ and Ca2+. However, NMDA receptors are 
three or four times more permeable to Ca2+ than calcium permeable AMPA receptors 
(Traynelis et al., 2010). Another consequence of the residues in the NMDA pore is a 
reduction of NMDAR activity at hyperpolarized potentials by a Mg2+ ion ‘stuck’ in the 
channel (Mayer, Westbrook, & Guthrie, 1984; Nowak, Bregestovski, Ascher, Herbet, & 
Prochiantz, 1984; Traynelis et al., 2010). This allows the NMDAR to act as a 
coincidence detector of pre/postsynaptic activity; the NMDAR is only active during 
postsynaptic depolarization and presynaptic release of glutamate (Mayer et al., 1984; 
Nowak et al., 1984; Tabone & Ramaswami, 2012).  
NMDAR-dependent Long Term Potentiation (LTP)/ Long Term Depression (LTD) 
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 It has been well established that the NMDA receptor is important in inducing long 
term changes in synaptic transmission; a phenomenon known as plasticity. The classic 
way to induce long-term potentiation (LTP) is by short (1-2 seconds), high frequency 
(>20Hz) stimulation of fibers which in turn causes the postsynaptic cell to fire. When 
postsynaptic NMDARs are activated during stimulation protocol, local Ca2+ 
concentration increases briefly (<2 seconds) which activates calcium/calmodulin 
dependent-protein kinase II (CAMKII) (Bliss & Collingridge, 1993; Malenka & Bear, 
2004). The net result of Ca2+ influx appears to be two-fold: the recruitment of additional 
AMPARs and/or phosphorylation of AMPARs (Malenka & Bear, 2004).  The effect of 
this modification to the synapse will be a greater response to glutamate released at the 
synapse over the course of hours, days or weeks. 
 In direct opposition of strengthening a synapse via LTP, a neuron must also have 
the ability to weaken a synapse. Interestingly, the NMDAR plays a critical role in 
inducing LTD as well as LTP. The induction of LTD is often accomplished 
experimentally by low frequency stimulation (0.5-5 Hz) and a slight postsynaptic 
depolarization to alleviate the Mg2+ ion blocking the NMDAR (Malenka & Bear, 2004). 
When NMDA antagonists are used LTD does not occur (Dudek & Bear, 1992) but 
experiments using NMDA itself as an agonist cause LTD (R. Li et al., 2004). The 
mechanism also appears to require Ca2+ influx through the NMDA receptor as 
experiments show uncaging of Ca2+ in dendritic spines causes LTD (Malenka & Bear, 
2004). In contrast to LTP, the induction of LTD via increased Ca2+ in dendritic spines 
occurs only when NMDARs are activated with low frequency stimulation. The specific 
intracellular cascades have not been entirely worked out. However, there is evidence 
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that suggests the dephosphorylation of protein kinase A (PKA) allows LTD to occur. 
Furthermore, there is evidence that protein phosphatase 1 (PP1) acts on PKA to induce 
LTD (Malenka & Bear, 2004). As one might expect, the consequence of LTD is a mirror 
of LTP: AMPA receptor density declines in a clathrin/dynamin-dendent manner and are 
dephosphorylated to reduce the probability of opening (Malenka & Bear, 2004). 
 The mechanisms of LTP and LTD discussed above are by no means exhaustive. 
There exists other means by which a neuron may change the strength of its synapses 
independent of the NMDA receptor. For instance, Shaffer collateral-CA1 synapses can 
undergo LTD independent of NMDA receptor via metabotropic glutamate (mGlut) 
receptors. Also, endogenous endocannabinoids released postsynaptically can activate 
presynaptic CB1 receptors to depress excitatory synaptic transmission in cerebellum 
and hippocampus (Malenka & Bear, 2004). However, it is clear from the abundant 
research in NMDA-dependent LTP/LTD that it is a robust mechanism of plasticity. 
Methods 
All experimental procedures used in this study are in compliance with the US 
National Institutes of Health regulations and were approved by the Institutional Animal 
Care and Use Committee of the University of Connecticut. Slice preparation details 
were similar to those used in previous studies (N. M. Bannon et al., 2016; N. Bannon et 
al., 2014; Zhang et al., 2015). Male Wistar rats of postnatal age (P) 21-38 days were 
decapitated under deep isoflurane anesthesia.  The brain was quickly extracted, and 
350 µm-thick coronal slices containing the visual cortex were prepared using a Leica 
VT100S vibratome.  The brain was constantly bathed in ice-cold oxygenated artificial-
cerebral spinal fluid (ACSF in mM: 125 NaCl, 25 NaHCO3, 25 glucose, 3 KCl, 1.25 
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NaH2PO4, 2 CaCl2, 1 MgCl2 bubbled with 95% O2/5% CO2, pH 7.4) during slice 
preparation. Coronal slices were allowed to recover for at least 1h at room temperature. 
Recordings were conducted by transferring slices to a recording chamber mounted on 
an Olympus BX-50WI microscope equipped with infrared differential interference 
contract (IR-DIC) optics. During recording, slices were submerged in oxygenated ACSF 
at 30-32 C.  
 
 We made whole-cell recordings from visually and physiologically identified 
pyramidal cells in layer 2/3 of the visual cortex using DIC microscopy. Identification of 
pyramidal neurons was reliable as demonstrated in previous work with biocytin labeling 
and morphological reconstruction of recorded neruons (M Volgushev, Vidyasagar, 
Chistiakova, & Eysel, 2000). Intracellular pipette solution contained in mM: 130 K-
Gluconate, 20 KCl, 10 HEPES, 10 Na-Phosphocreatine, 4 Mg-ATP, 0.3 Na2-GTP (pH 
7.4 with KOH). All excitatory postsynaptic currents (EPSCs) were recorded in Layer 2/3 
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and induced by a pair of stimulation electrodes (S1 and S2) in Layer 4 (Fig. 1). 
Stimulation current intensities were tuned to evoke monosynaptic EPSCs in the 
recorded neuron.  Paired stimuli (50 ms interstimulus interval) were applied to S1 and 
S2 in alternating sequence once per 7.5 seconds, so that each input was stimulated 
with paired pulses each 15 seconds. 
Control protocol for isolated and mixed EPSCs is as follows. Recordings were 
conducted in voltage-clamp mode with holding potential at -50mV. Pharmacologically 
isolated AMPA EPSCs were recorded under 5µM picrotoxin (PTX; Sigma, St. Louis MO, 
USA) and D-(--)-2-amino-5-phosphonopentoic acid (APV 20µM; Tocris, Bristol, UK). 
Picrotoxin was dissolved in the ACSF directly. APV (Tocris, Bristol, UK) was dissolved 
in water to a 50mM stock before being added to ACSF.  Pharmacologically isolated 
NMDA EPSCs were recorded under 5µM PTX (Sigma, St. Louis MO, USA) and 6,7-
dinitroquinoxaline-2,3(1H,4H)-dione (DNQX 10µM; Sigma, St. Louis MO, USA). DNQX 
(Sigma, St. Louis MO, USA) was dissolved in water to a 5mM stock before being added 
to ACSF. Mixed currents were recorded with 2-100µM PTX (Sigma, St. Louis MO, 
USA), 1mM glycine, and 1nM tetrodotoxin (TTX; Tocris, Bristol UK). Following control 
protocol, 20µM Adenosine (Sigma, St. Louis MO, USA) was applied to the bath and 
evoked EPSCs were recorded. Adenosine (Sigma, St. Louis MO, USA) was dissolved in 
ACSF to a 1mM stock before being applied to the bath. Control solution was then used 
to wash ADO from the bath and evoked EPSCs were recorded. The identity of all 
evoked EPSCs were confirmed using selective antagonists APV and DNQX. After 
recordings were conducted at -50mV, the holding potential was varied to determine 
current-voltage relationship at -30, -40, -60, -70, and -80mV. In addition, depolarized 
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holding potentials (-30 and -40mV) allowed us to determine if EPSCs were 
contaminated with inhibitory currents. Only currents that were still depolarizing at these 
holding potentials were considered excitatory and included in the analysis.  
Data analysis 
Using custom-written programs in MatLab (© The MathWorks, Natick MA, USA), 
EPSC amplitudes were measured as the difference between the mean membrane 
potential during two or three measurement windows. The amplitude of EPSCs was 
determined by placing a baseline window before the onset of an event and a 
measurement window at the peak of the EPSC. For mixed current experiments the 
baseline window was placed in the same manner as stated before. The AMPA window 
was set at the fast onset peak and the NMDA window was set when an event returned 
to baseline under APV (a selective NMDA antagonist; Fig. 2B). All inputs included in the 
analysis fulfilled the criteria of (1) stability of EPSC amplitude during the control period, 
(2) stability of the onset latency and kinetics of the slope of the EPSC, (3) absence of 
inhibitory currents when the holding potential was depolarized to -30 and -40mV during 
APV and DNQX conditions (Fig. 2B). Measurement windows for paired pulse 
stimulation paradigm were the same duration but displaced by the inter-pulse interval 
(50 ms). 
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Statistical tests were conducted using a Student’s t-test, repeated measures 
ANOVA, or univariate ANOVA with post-hoc comparisons (Bonferroni). Error bars 
represent the standard error of the mean. 
  21 
 
  22 
Results 
The experiments that follow aim to elucidate whether NMDA-mediated currents 
are suppressed differentially from AMPA-mediated currents in layer 2/3 of rat visual 
cortex. In order to accomplish this, we conducted experiments that systematically 
isolated different components of excitatory postsynaptic currents. We investigated the 
effect of adenosine on pharmacologically isolated AMPA and NMDA-mediated currents. 
In these experiments, we demonstrate a similar reduction in EPSC amplitude 
concurrent with an increase in the paired pulse ratio (suggesting a presynaptic action). 
In addition, the voltage-dependence of the evoked AMPA and NMDA-mediated currents 
further corroborates their identity. In our final preparation, we measured the effect of 
adenosine on co-occurring AMPA- and NMDA-mediated components in which the 
NMDA/AMPA ratio was maintained.    
Adenosine reduces the amplitude of pharmacologically isolated AMPA currents 
To study the effects of adenosine in layer 2/3 pyramidal neurons on AMPA-
mediated currents we recorded EPSCs evoked by a paired-pulse stimulus under the 
background of a selective NMDA-antagonist (APV) and GABAA antagonist (PTX; Fig. 
3A and Fig. 3B). After recording 80-100 sweeps to establish a stable baseline, 20µM 
adenosine (ADO) was washed into the bath (Fig. 3A and Fig. 3B). It was assumed that 
ADO concentrations in the bath reached 20µM after approximately 5 minutes of wash in 
(Fig. 3B). The concentration of adenosine that robustly reduced the amplitude of 
excitatory potentials (20µM) was established by previous experiments conducted by our 
laboratory (N. Bannon et al., 2014). Adenosine was subsequently washed out of the 
bath using control solution for approximately 5 minutes (Fig. 3B). After washout, DNQX 
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was washed into the bath to both confirm the identity of the EPSC as an AMPA-
mediated event and to determine a potential inhibitory current contamination. All inputs 
with inhibitory events were not included in our data set.  
Under the application of adenosine, AMPA-mediated EPSCs were potently 
reduced to 51.1 ± 4.59% of baseline (Fig. 3C; p<0.001). During washout of adenosine, 
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the AMPA-mediated EPSC returned to 108 ± 20.7% of baseline (Fig. 3C; n.s). The bath 
application of DNQX, a selective AMPA-antagonist, reduced the AMPA-mediated EPSC 
to 4.31 ± 2.43% of baseline (Fig. 3C; p<0.001). Concurrently, we observed a modest 
increase in the paired-pulse ratio (PPR) under bath application of adenosine (Fig. 4A; 
p=0.067). An increase in PPR is commonly interpreted as a decrease in release 
probability (Stevens, 1993) thus suggesting a presynaptic mechanism of ADO 
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modulation. At differing holding potentials (-80, -70, -60, -50, -40, and -30 mV) a clear 
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voltage-dependent relationship was seen during all conditions (Fig. 4B).  
Adenosine reduces the amplitude of pharmacologically isolated NMDA currents   
 The effects of adenosine in layer 2/3 pyramidal neurons on NMDA-mediated 
currents were studied by pharmacologically isolating NMDA currents with DNQX and 
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PTX in control solution and subsequent bath application of adenosine. Similar to AMPA-
mediated currents, adenosine robustly reduced the amplitude of NMDA-mediated 
EPSCs to 44.5 ± 4.94% of baseline (Fig 5C; p<0.001). During the washout of 
adenosine, NMDA-mediated EPSCs returned to 101 ± 10.5% of baseline (Fig. 5C; n.s). 
Wash-in of the selective NMDA-antagonist (APV) reduced NMDA-mediated EPSCs to 
8.83 ± 4.55% of baseline (Fig. 5C; p<0.001). We observed a significant increase in the 
paired-pulse ratio to 142 ± 17.3% of baseline (Fig. 6A; p=0.001) suggesting a reduction 
in release probability and therefore a presynaptic action of adenosine. In addition, we 
observed a characteristic voltage-dependent relationship of the NMDA receptor at 
holding potentials between -30 and -80mV, where holding potentials less than -50mV 
passed little current due to a Mg2+ ion obstructing the channel (Fig. 6B; Nowak et al., 
1984). It is important to note that our results show a clear difference in the voltage 
dependence of AMPA-mediated (Fig. 4B) and NMDA-mediated currents (Fig. 6B). 
These results indicate that we are truly recording isolated AMPA- and NMDA-mediated 
currents. Our results show similar voltage dependent relationships that have been 
previously identified for NMDA and non-NMDA-mediated currents (Klishin et al., 1995).  
  
Adenosine reduces the amplitudes of mixed NMDA and AMPA currents proportionally 
 To study the effect of adenosine in layer 2/3 pyramidal neurons on mixed, AMPA 
and NMDA-mediated, currents we recorded EPSCs evoked by a single pulse under the 
background of PTX, TTX, and NMDAR co-activator glycine.  A single pulse paradigm 
was used in conjunction with a low concentration of PTX (2µM) and TTX (1nM) to 
reduce slice seizures. Once a stable baseline was recorded (80-100 sweeps or 
approximately 10mins), 20µM ADO was washed into the bath (Fig. 7B and Fig.7C). 
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ADO was allowed to fully wash in (5mins) and the last 20 sweeps were averaged for 
analysis (Fig. 7B and Fig. 7C). ADO was subsequently washed out of the bath (10mins; 
Fig. 7B and Fig. 7C). After washout, 20µM APV was washed into the bath to isolate 
AMPA-mediated currents (Figure 7C). This allowed us to determine appropriate 
placement of NMDA-mediated measurement windows (see Methods). DNQX, a 
selective AMPA antagonist, was washed into the bath at the end of the experiment to 
confirm the absence of inhibitory currents at all holding potentials (-30 through -80mV; 
not shown).  
During bath application of adenosine, we observed a reduction in the amplitude 
of both AMPA-mediated (Fig. 8A, 37.8 ± 5.92% of baseline; p<0.001) and NMDA-
mediated (Fig. 8A, 35.7 ± 8.91% of baseline; p<0.001) components of EPSCs. The 
effects of adenosine could be reversed during washout where the AMPA and NMDA 
components returned to 80.1 ± 5.79% (p=0.079) and 86.3 ± 7.19% (p=0.778) of 
baseline, respectively (Fig. 8A). The application of the NMDA-antagonist, APV, reduced 
NMDA-mediated currents to 14.8 ± 5.05% of baseline (Fig. 8A; p<0.001). When 
compared, the mean amplitudes of AMPA or NMDA-mediated EPSCs under adenosine 
were not statistically different from each other (Fig. 8A, T-test; p=0.157). When a ratio 
was made of NMDA to AMPA-mediated EPSCs there was no significant difference 
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between control and the wash-in of adenosine (Fig. 8B, T-test; p=0.644). Furthermore, 
when the amplitudes of isolated AMPA and NMDA-currents under adenosine were 
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compared there was no statistical difference (not shown, T-test; p=0.338). 
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Discussion 
In accord with previous work from our lab, adenosine robustly reduced the 
amplitude of EPSCs in L2/3 of rat visual cortex (N. Bannon et al., 2014). However, it 
was not previously known whether adenosine worked preferentially on NMDA-mediated 
or AMPA-mediated currents in the cortex. In dopamine neurons of the rat midbrain, 
adenosine via activation of presynaptic A1Rs reduced NMDA-mediated currents 20 
times more potently than AMPA-mediated currents (Y.-N. Wu et al., 1999). Their 
proposed mechanism suggests that the majority of NMDAR activation is due to 
glutamate spillover therefore a dilute concentration of glutamate would preferentially 
reduce NMDA-mediated events (Y.-N. Wu et al., 1999). In contrast, work conducted in 
the hippocampus has shown that AMPA and NMDA-mediated events are reduced 
equally by adenosine (Garaschuk et al., 1992; Perkel & Nicoll, 1993) and increases in 
release probability change NMDA/AMPA-mediated events proportionally (Tong & Jahr, 
1994). 
In our experiments we demonstrate that NMDA- and AMPA-mediated currents 
are reduced proportionally in mixed current recordings of L2/3 rat visual cortex (Fig. 8a). 
Thus, the NMDA/AMPA ratio was maintained during wash-in of adenosine (Fig. 8b). In 
our pharmacologically isolated preparations, we observe an increase in the paired-pulse 
ratio (EPSC2/EPSC1) which is inversely related to release probability (Stevens, 1993; 
Fig. 4a and Fig. 6a). This result suggests that adenosine may be acting on A1Rs thus 
reducing the amount of glutamate released. Therefore, adenosine did not confer with a 
selective reduction in NMDA-mediated currents (Fig. 8a).  
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The implications of our findings reach beyond a fundamental understanding of 
adenosine’s role in synaptic transmission in the visual cortex. A1R activation during the 
induction of plasticity has been demonstrated to have long term effects on synaptic 
transmission. In CA1 region of the hippocampus, long-term potentiation (LTP) was 
nearly blocked by an adenosine analog, 2-chloroadenosine (CADO). Further studies 
have shown that adenosine itself may block LTP induction and antagonizing the A1 
receptor using 8-cylcopentyl-1,3-dipropylxanthine (DPCPX) prevents adenosine-
mediated inhibition of LTP (De Mendonça & Ribeiro, 2001). A plausible mechanism for 
the effect of adenosine on preventing LTP could be a reduction in the amount of 
activated NMDARs. LTP requires an influx of Ca2+ through the NMDA receptor. NMDA 
currents were inhibited by CADO in pyramids of dissociated hippocampus (de 
Mendonça, Sebastião, & Ribeiro, 1995). In CA1-CA3 regions of the hippocampus, A1 
antagonist, CPT, was shown to increase NMDA-mediated but not AMPA-mediated 
currents (Klishin et al., 1995). This potential preference for modulation of NMDA-
mediated currents could be explained by phosphorylation of NMDA receptor subunits 
downstream of protein kinase A activation via adenosine receptors (Chen & Roche, 
2007). 
Previous work from our lab has demonstrated that adenosine may serve a 
homeostatic role in regulation of synaptic plasticity. The Hebbian model of learning 
generally states that synapses activated before postsynaptic firing will be potentiated 
(Magee & Johnston, 1997). Hence the common interpretation, ‘synapses that fire 
together, wire together’. However, Hebbain-type long-term plasticity creates a positive 
feedback loop that cannot explain the variability of synaptic weights (N. M. Bannon et 
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al., 2016). In layer 2/3 of rat visual cortex, synapses are modulated at homosynaptic 
(active) as well as heterosynaptic (non-active) inputs (Maxim Volgushev et al., 2016). 
Furthermore, heterosynaptic inputs were modulated by the same activity as 
homosynaptic inputs. The direction of change was weight-dependent so that overall 
synaptic input was preserved (Maxim Volgushev et al., 2016). Recent experiments have 
demonstrated that in L2/3 of rat visual cortex, adenosine strengthened weight-
dependent plasticity whereas adenosine antagonists prevent it (N. M. Bannon et al., 
2016). 
The present study adds to the narrative of adenosine’s role in modulation of 
plasticity. Here, we demonstrate that NMDA-mediated currents are not preferentially 
reduced by adenosine in L2/3 pyramids of visual cortex. Thus, activation of adenosine 
receptors and postsynaptic modulation of NMDA-mediated currents are likely not 
mediating the effects of adenosine on weight-dependent plasticity. 
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